Clinical Trial Detail

NCT ID NCT02476786
Title Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements yes
Sponsors Washington University School of Medicine
Indications

Her2-receptor negative breast cancer

Therapies

Anastrozole

Fulvestrant

Goserelin

Tamoxifen

Exemestane

Age Groups: senior

Additional content available in CKB BOOST